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Objectives: Currently, laparoscopic distal pancreatectomy (LDP) is regarded as a safe and effective
surgical approach for lesions in the body and tail of the pancreas. This review compares outcomes of the
laparoscopic technique with those of open distal pancreatectomy (ODP) and assesses the efficacy, safety
and feasibility of each type of procedure.
Methods: Comparative studies published between January 1996 and April 2012 were included. Studies
were selected based on specific inclusion and exclusion criteria. Evaluated endpoints were operative
outcomes, postoperative recovery and postoperative complications.
Results: Fifteen non-randomized comparative studies that recruited a total of 1456 patients were
analysed. Rates of conversion from LDP to open surgery ranged from 0% to 30%. Patients undergoing
LDP had less intraoperative blood loss [weighted mean difference (WMD) -263.36.59 ml, 95% confidence
interval (CI) -330.48 to -196.23 ml], fewer blood transfusions [odds ratio (OR) 0.28, 95% CI 0.11–0.76],
shorter hospital stay (WMD -4.98 days, 95% CI -7.04 to -2.92 days), a higher rate of splenic preservation
(OR 2.98, 95% CI 2.18–3.91), earlier oral intake (WMD -2.63 days, 95% CI -4.23 to 1.03 days) and fewer
surgical site infections (OR 0.37, 95% CI 0.18–0.75). However, there were no differences between the two
approaches with regard to operation time, time to first flatus and the occurrence of pancreatic fistula and
other postoperative complications.
Conclusions: Laparoscopic resection results in improved operative and postoperative outcomes com-
pared with open surgery according to the results of the present meta-analyses. It may be a safe and
feasible option for patients with lesions in the body and tail of the pancreas. However, randomized
controlled trials should be undertaken to confirm the relevance of these early findings.
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Introduction
Laparoscopic surgery is now widely accepted and recognized as a
standard technique in many surgical procedures.1,2 Initially, the
laparoscopic approach was not commonly used in pancreatic
resection; however, increasing experience means laparoscopic
distal pancreatectomy (LDP) is now performed more frequently
in the surgical management of benign, non-invasive and even
malignant lesions in the body and tail of the pancreas.3 Some
studies have reported LDP to be associated with decreased intra-
operative blood loss, a higher rate of splenic conservation, shorter
hospital stay and less morbidity compared with open distal pan-
createctomy (ODP).4–6 By contrast, other studies report findings
in favour of ODP.7,8 Because these various reports indicate a dis-
crepancy in the published literature, the present authors consid-
ered it necessary to summarize and analyse the published data to
provide evidence to determine whether the literature supports the
use of a laparoscopic approach as an alternative to open surgery in
the resection of the distal pancreas.*These authors contributed equally to this work.
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Materials and methods
Study selection
Major databases including PubMed (MEDLINE), EMBASE, the
Science Citation Index Expanded and the Cochrane Central Reg-
ister of Controlled Trials (CENTRAL) in the Cochrane Library
were searched for studies comparing outcomes in LDP and ODP,
published in English from January 1996 to April 2012 (the first
LDP was described in 1996). The medical search headings (MeSH)
‘laparoscopy’, ‘pancreatectomy’, ‘comparative study’ and combina-
tions of these were used, as were the keywords ‘laparoscopic’, ‘open
distal pancreatic resection’, ‘left pancreatic resection’, ‘pancreatic
surgery’, ‘distal pancreatectomy’ and ‘minimally invasive surgery’.
The reference lists of articles identified were examined to find
relevant studies that had not been identified by the database
searches. Only comparative clinical trials with full-text descrip-
tions were included. The final inclusion of articles was determined
by consensus between authors TJ and KA; when this failed, a third
author (JJX) adjudicated.
Inclusion and exclusion criteria
Two authors (TJ and KA) identified and screened the search find-
ings for potentially eligible studies. Inclusion criteria required the
studies to: (i) be written in English and published in peer-
reviewed journals; (ii) be human studies; (iii) examine at least one
of the predetermined outcomes, and (iv) provide clear documen-
tation of the operative techniques as ‘laparoscopic’ or ‘open’. In
contexts in which multiple studies were published from the same
institution and/or by the same authors, either the higher-quality
study or the most recent publication was included in the analysis.
Exclusion criteria excluded: (i) abstracts, letters, editorials,
expert opinions, case reports, reviews and studies lacking control
groups; (ii) studies that included only patients undergoing spleen-
Potentially relevant abstracts captured and screened 
MEDLINE (PubMed), EMBASE, Science Citation Index 
Expanded and Cochrane Central Register of Controlled Trials 
(CENTRAL) in the Cochrane Library. 
Articles retrieved for more detailed evaluation
n = 26
High-quality articles included for 
systematic review and meta-analysis: n = 15   
(Retrospective studies: n = 14) 
(Prospective non-randomized study: n = 1)
Articles excluded (n = 401) 
Duplicated articles: 49 
Not relevant: 146 
Only conference abstracts: 35 
Reviews or expert opinions: 48 
Letters: 3 
Case reports: 43 
Animal studies: 13 
Non-English: 27  
Non-comparative studies: 37
Articles excluded (n = 5) 
Converted cases included in the open 
group (n = 1)
Patients with only spleen-preserving 
and splenic vessel-preserving LDP or 
ODP (n = 1) 
Repeated reports (n = 3)
n = 427
Figure 1 Flow diagram depicting the process of identifying and selecting studies for inclusion. LDP, laparoscopic distal pancreatectomy;
OPD, open distal pancreatectomy
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preserving LDP or ODP, and (iii) studies in which patients con-
verted to open surgery were included in the ODP group.
Outcomes of interest and definitions of complications
The following outcomes were used to compare patients undergo-
ing LDP with those undergoing ODP. Operative outcomes
included operative time, intraoperative blood loss, blood transfu-
sion and splenic preservation. Postoperative recovery comprised
time to oral intake, time to first flatus and duration of postopera-
tive hospital stay. Postoperative complications included pancreatic
fistula, clinically significant fistula [International Study Group on
Pancreatic Fistula (ISGPF) grades B and C9], mortality, surgical
site infection, intra-abdominal abscess, intra-abdominal fluid col-
lection, postoperative haemorrhage, reoperation and readmission.
Data extraction and quality assessment
Data were extracted by two independent observers (WH and
MAJ) using standardized forms. Data recorded included patient
and study characteristics, pathological characteristics of resected
specimens, and operative and postoperative outcomes. The
Table 1 Characteristics of included studies
Author(s) Year Country Study
design
LDP, n ODP, n Inclusion/exclusion
criteria
Matching/
comparable
factorsa
Study
qualityb
(point
scoring
scale)
Velanovich4 2006 USA Retro 15 15 Not specified 2, 4 *******
Teh et al.5 2007 USA Retro 12 16 Benign pancreatic disease (I) 1, 2, 3, 4 ******
Matsumoto et al.6 2008 Japan Retro 14 19 Benign or borderline malignant pancreatic
tumour (I)
1, 2, 3 *********
Kim et al.26 2008 Korea Retro 93 35 Benign pancreatic disease (I) 2, 3, 4 *******
Kooby et al.18 2008 USA Retro 23 189 Ductal adenocarcinoma (I) 1, 2, 3 ******
Background IPMN/cystadenocarcinoma (E)
Baker et al.21 2009 USA PNR 27 85 Not specified 1, 3, 4 ******
Jayaraman et al.27 2010 USA Retro 100 100 Additional organ resection (E) None *******
DiNorcia et al.28 2010 USA Retro 71 168 Laparoscopic-assisted DP (E) 1 ******
DP as part of a completion pancreatectomy (E)
Concomitant portomesenteric venous resection
and reconstruction (E)
DP secondary to debridement for necrotizing
pancreatitis (E)
Non-pancreatic primary neoplasms or pancreatic
injury (E)
Casadei et al.29 2010 Italy Retro 22 22 Endocrine and cystic pancreatic tumours (I) 1, 2 *******
Ductal adenocarcinoma (E)
Waters et al.30 2010 USA Retro 18 22 Urgent surgery (E) Concurrent major surgery an
indication for surgery of acute or chronic
pancreatitis (E)
1, 4 ******
Mehta et al.31 2012 France Retro 30 30 DP for non-pancreatic pathologies (E) 2, 3, 4 ******
Resections amounting to less than a DP or total
pancreatectomy (E)
Butturini et al.32 2012 Italy Retro 43 73 Benign and borderline neoplasms (I) 2, 3 ********
Ductal cancer or other malignant tumours (E)
Abu et al.38 2011 UK Retro 35 16 Additional organ resections (E) 3, 4 *****
Fox et al.33 2012 Canada Retro 42 76 Additional organ resection (E) 1, 3, 4 *****
Limongelli et al.34 2012 Italy Retro 16 29 Only tumour enucleation was accomplished (E) 1, 2, 4 ******
Additional organ resection (E)
aMatching/comparable factors are: 1, American Society of Anesthesiologists (ASA) status; 2, type of pancreatic pathology; 3, mean size of tumour,
and 4, presence of chronic pancreatitis.
bBased on Newcastle–Ottawa Scale with maximum of **** for selection, ** for comparability, and ** for outcome.
LDP, laparoscopic distal pancreatectomy; ODP, open distal pancreatectomy; Retro, retrospective; PNR, prospective non-randomized; I, inclusion
criteria; E, exclusion criteria; IPMN, intraductal papillary mucinous neoplasm; DP, distal pancreatectomy.
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quality of studies was assessed using the modified Newcastle–
Ottawa Scale, modified to reflect the needs of this study.10 The
maximum numbers of points awarded in the selection, compara-
bility and outcome categories were three, four and two, respec-
tively. Studies achieving six or more points were considered to be
of high quality.11 Only these studies were included in the final
analyses. Subgroup analyses included all studies (high and low
quality) in order to obtain a cumulative result.
Statistical analysis
Meta-analysis was performed using Review Manager Version 5.0
(Cochrane Collaboration, Oxford, UK). For continuous variables,
treatment effects were expressed as the weighted mean difference
(WMD) with the corresponding 95% confidence interval (CI).
For categorical variables, treatment effects were expressed as the
odds ratio (OR) with the corresponding 95% CI. Heterogeneity
was evaluated using the chi-squared test and a P-value of <0.1 was
considered to indicate statistical significance.12 The fixed-effects
model was initially calculated for all outcomes,13 but if the test
rejected the assumption of homogeneity of studies, random-
effects analysis was performed.14 If data in the included studies
were considered to be inappropriate for meta-analysis, some out-
comes were presented descriptively. Sensitivity analyses were per-
formed by removing individual studies from the dataset and
analysing the effect on the overall results to identify sources of
significant heterogeneity. Subgroup analyses were undertaken by
including high-quality studies to present cumulative evidence.
Table 2 Operative and postoperative outcomes of included comparative studies
Author Conversion Spleen
preservation
Operation
time, min,
mean/median
(range)
Hospital
stay, days,
mean/median
(range)
PF/clinically
significant PF
Mortality
n (%) n (%) n (%) n (%)
LDP ODP LDP ODP LDP ODP LDP ODP LDP ODP
Velanovich4 3 (20) NA NA NA NA 5 (3–9) 8 (6–23) 2 (13) 2 (13) NA NA
Teh et al.5 2 (16.7) NA NA 212 (60–360) 278 (180–420) 6.2 (3–16) 10.6 (7–19) 1 (8.3) 1 (6.2) 0 0
Matsumoto et al.6 1 (7.1) NA NA 290.7 53.2a 213.8 84.6a 12.9 4.8a 23.8 11.8a 0 2 (10.5) 0 0
Kim et al.26 NA 38 (40.8) 2 (5.7) 195 (82–453) 190 (88–482) 10 (5–36) 16 (8–65) 8 (8.6) 5 (14.3) 0 0
Kooby et al.18 20 (12.6) 43 (30) 24 (12) 230 97a 216 100a 5.9 3.8a 9.0 6.0a 37 (26)/16 (11) 64 (32)/36 (18) 0 1 (1)
Baker et al.21 1 (3.7) NA NA 236 82a 253.2 292.3a 4.0 0.3a 8.6 0.7a 6 (22)/4 (14.8) 12 (14)/12 (14.1) 0 1 (1.2)
Jayaraman et al.27 32 (30) 14 (42.4) 33 (14.0) 195 160 5 6 8 (10.8) 13 (5.5) 0 2 (0.8)
DiNorcia et al.28 24 (25.3) 11 (15.5) 26 (15.8) 191 (163–214) 192 (157–236) 5 (4–6) 6 (5–8) 8 (11.3) 25 (14.9) 0 1 (0.6)
Casadei et al.29 0 4 (18.2) 4 (18.2) 225 83b 145 49b 8.0 1.3b 11.0 3.0b 2 (9.1) 4 (18.2) 0 0
Waters et al.30 2 (11) 5 (28) 3 (14) 224 (100–346) 234 (136–437) 6 (3–34) 8 (3–25) 2 (11.1) 4 (18.2) 0 0
Mehta et al.31 0 21 (70) 9 (30) 188 72a 226 87a 8.7 4.2a 12.6 8.7a 5 (16.7)/5 (16.7) 4 (13.3)/4 (13.3) 0 1 (3.3)
Butturini et al.32 0 19 (44.2) 8 (11) 180 180 8 9 12 (27.9) 10 (13.7) 0 0
Abu et al.38 0 14 (40) 3 (19) 200 (120–420) 225 (120–460) 7 (3–25) 11 (5–46) 10 (29) 7 (44) NA NA
Fox et al.33 5 (11.91) 15 (35.7) 17 (22.4) 304 (265–348) 281 (247–333) 5 (4–6) 7 (6–9) 12 (28.6)/0 (0) 10 (13.2)/4 (5.3) NA NA
Limongelli et al.34 1 (6) 5 (31) 3 (14) 204 31a 160 35a 6.4 2.3a 8.6 1.7a 3 (18)/1 (6) 6 (20)/5 (17.2) 0 (0) 1 (3)
aMean  standard deviation.
bMedian  standard deviation.
PF, pancreatic fistula; LDP, laparoscopic distal pancreatectomy; ODP, open distal pancreatectomy; NA, not available.
Table 3 Definitions of postoperative pancreatic fistula in the included
studies
Author Definition of postoperative
pancreatic fistula
Velanovich4 Amylase-rich fluid after PoD 3
Teh et al.5 Amylase >1000 after PoD 3
Matsumoto et al.6 Fluid amylase >5000 U/l after PoD 7
Kim et al.26 Drainage of >30 ml with amylase level >5-fold
more than serum level 5 days after surgery
Kooby et al.18 Fluid amylase >350 mg/dl or need for
postoperative percutaneous fluid collection
Baker et al.21 ISGPF definition
Jayaraman et al.27 ISGPF definition
DiNorcia et al.28 ISGPF definition
Casadei et al.29 ISGPF definition
Waters et al.30 Not defined
Mehta et al.31 ISGPF (grades B and C)
Butturini et al.32 ISGPF definition
Abu et al.38 ISGPF definition
Fox et al.33 ISGPF definition
Limongelli et al.34 ISGPF definition
PoD, postoperative day; ISGPF, International Study Group on Pancreatic
Fistula.
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Funnel plots were constructed to evaluate potential publication
bias15 based on the major complication of pancreatic fistula.
Results
Description of trials included in the meta-analysis
The search strategy initially generated 427 relevant clinical reports.
Finally, 26 full-text articles4–6,16–38 were identified for further inves-
tigation. Of these, two studies16,17 were excluded for various
reasons: one study included patients in whom LDP had been
converted to open surgery in the ODP group,16 and the other
included patients who had undergone only spleen-preserving
and splenic vessel-preserving LDP or ODP.17 Three studies18–20
reported from the same institution described overlapping
patient populations. According to the inclusion criteria, the
highest-quality study18 was included in the present meta-analysis.
Similarly, of two studies published by Baker et al.,21,22 the higher-
quality study21 was included. Six studies were low-quality studies,
which should be excluded. Finally, 15 high-quality studies were
identified for inclusion; these included one prospective non-
randomized study and 14 retrospective studies. Figure 1 shows the
process by which comparative studies were selected for inclusion in
the present meta-analysis.
Study and patient characteristics
The study characteristics, quality and comparability assessments
are shown in Table 1. Details of outcome measures are listed in
Table 2. Definitions of pancreatic fistula are shown in Table 3. A
total of 1456 patients were included; this number included 561
and 895 patients in the LDP and ODP groups, respectively. Five
studies5,6,26,29,32 looked at benign tumours only. The remaining 10
studies4,19,21,27,28,30,31,33,34,38 looked at both benign and malignant
lesions. Most of the studies conducted a matched comparative
analysis. The results of the analyses are summarized in Table 4.
Operative outcomes
Five studies6,19,21,31,34 reported operation time. The present analysis
showed no statistically significant difference between the two
groups (WMD 19.71 min, 95% CI -10.01 to 49.44; P = 0.19).
Similarly, findings in five studies6,19,21,31,34 were pooled to provide
an estimation of mean blood loss in each of the LDP and ODP
groups. Intraoperative blood loss was significantly lower in the
LDP group than in the ODP group (WMD -263.36 ml, 95% CI
-330.48 to -196.23; P < 0.00001). Additionally, fewer patients
required blood transfusions in the LDP group (OR 0.28, 95% CI
0.11–0.76; P = 0.01). The rate of splenic preservation was identi-
fied as significantly higher in the LDP group than in the ODP
group (OR 2.98, 95% CI 2.18–3.91; P < 0.00001). Forest plots are
shown in Fig. 2.
Postoperative recovery
Patients in the LDP group had a shorter postoperative hospital
stay (WMD -4.98 days, 95% CI -7.04 to -2.92; P < 0.00001) and
were able to resume flatus earlier (WMD -1.80 days, 95% CI
-2.14 to -1.47; P < 0.000001) than their counterparts in the ODP
group (Fig. 3). However, there was no significant difference
between the groups in time to oral intake (WMD -2.63 days, 95%
CI -4.23 to 1.03; P = 0.001).
Table 4 Results of meta-analysis comparing outcomes in laparoscopic and open distal pancreatectomy in high-quality studies
Outcome of interest Studies, n Patients, n OR/WMD 95% CI P-value*
Operative outcomes
Operation time, min 5 343 19.71 -10.01 to 49.44 0.19
Intraoperative blood loss, ml 5 343 -263.36 -330.48 to -196.23 <0.00001
Blood transfused 5 375 0.28 0.11–0.76 0.01
Splenic preservation 10 1148 2.98 2.18–4.06 <0.00001
Postoperative recovery
Time to oral intake, days 2 161 -2.63 -4.23 to -1.03 0.001
Time to first flatus, days 2 161 -1.80 -2.14 to -1.47 <0.00001
Hospital stay, days 5 343 -4.98 -7.04 to -2.92 <0.00001
Postoperative complications
Clinically significant fistula 4 335 0.67 0.41–1.09 0.11
Postoperative haemorrhage 4 329 1.87 0.59–5.95 0.29
Intra-abdominal abscess 6 331 0.78 0.25–2.45 0.67
Intra-abdominal fluid collections 3 304 1.47 0.67–3.22 0.34
Surgical site infection 5 264 0.37 0.18–0.75 0.006
Mortality 11 1155 0.61 0.16–2.27 0.46
Reoperation 8 683 0.90 0.43–1.84 0.76
Readmission 5 772 0.70 0.41–1.21 0.20
WMD, weighted mean difference; OR, odds ratio; 95% CI, 95% confidence interval.
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Study or Subgroup
Matsumoto et al. 2008
Baker et al. 2009
Kooby et al. 2010
Mehta et al. 2012
Limongelli et al. 2012
Total (95% CI)
Heterogeneity: Tau² = 1225.38; Chi² = 18.60, d.f. = 4 (P = 0.0009); I² = 78%
Test for overall effect: Z = 1.11 (P = 0.27)
Mean
290.7
236
238
188
204
SD
53.2
82
68
72
31
Total
14
27
23
30
16
110
Mean
213.8
253.2
216
226
160
SD
84.6
292.3
69
87
35
Total
19
85
70
30
29
233
Weight
18.6%
13.5%
22.4%
20.3%
25.2%
100.0%
IV, Random, 95% CI
76.90 (29.74, 124.06)
–17.20 (–86.61, 52.21)
22.00 (–10.15, 54.15)
–38.00 (–78.41, 2.41)
44.00 (24.18, 63.82)
20.27 (–15.60, 56.14)
Year
2008
2009
2010
2011
2012
Lap Open Mean Difference Mean Difference
IV, Random, 95% CI
–100 –50 0 50 100
Favours Lap Favours Open
Study or Subgroup
Matsumoto et al. 2008
Baker et al. 2009
Kooby et al. 2010
Mehta et al. 2012
Limongelli et al. 2012
Total (95% CI)
Heterogeneity: Chi² = 5.77, d.f. = 4 (P = 0.22); I² = 31%
Test for overall effect: Z = 6.58 (P < 0.00001)
Mean
247.1
219.4
422
294
160
SD
227.4
159
473
245
185
Total
14
27
23
30
16
110
Mean
400.3
612.6
751
726
365
SD
423.5
744.02
853
709
215
Total
19
85
70
30
29
233
Weight
13.1%
23.1%
8.5%
9.2%
46.1%
100.0%
IV, Fixed, 95% CI
–153.20 (–377.81, 71.41)
–393.20 (–562.36, –224.04)
–329.00 (–607.02, –50.98)
–432.00 (–700.43, –163.57)
–205.00 (–324.75, –85.25)
–273.10 (–354.39, –191.81)
Year
 2008
 2009
 2010
 2011
 2012
ecnereffiDnaeMecnereffiDnaeMnepOpaL
IV, Fixed, 95% CI
–500 –250 0 250 500
Favours Lap Favours Open
Study or Subgroup
Kim et al. 2008
Matsumoto et al. 2008
Abu et al. 2011
Fox et al. 2012
Limongelli et al. 2012
Total (95% CI)
Total events
Heterogeneity: Chi² = 0.98, d.f. = 4 (P = 0.91); I² = 0% 
Test for overall effect: Z = 1.61 (P = 0.11)
Events
2
0
1
4
3
10
Total
93
14
35
42
16
200
Events
1
2
2
11
8
24
Total
35
19
16
76
29
175
Weight
8.0%
11.6%
14.9%
39.7%
25.9%
100.0%
M–H, Fixed, 95% CI
0.75 (0.07, 8.51)
0.24 (0.01, 5.44)
0.21 (0.02, 2.46)
0.62 (0.19, 2.09)
0.61 (0.14, 2.71)
0.52 (0.24, 1.15)
Year
2008
2008
2011
2011
2012
oitaRsddOoitaRsddOnepOpaL
M–H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours Lap Favours Open
(a)
(b)
(c)
Figure 2 Forest plots illustrating the results of a meta-analysis comparing operative outcomes in laparoscopic and open distal pancreate-
ctomy. Pooled odds ratios (ORs) or weighted mean differences (WMDs) with 95% confidence intervals (CIs) were calculated using the
fixed-effects model or the random-effects model. (a) Operation time. (b) Intraoperative blood loss. (c) Blood transfusions. (d) Splenic
preservation. SD, standard deviation
716 HPB
HPB 2012, 14, 711–724 © 2012 International Hepato-Pancreato-Biliary Association
Postoperative complications
There was no difference in rates of clinically significant fistula (OR
0.67, 95% CI 0.41–1.09; P = 0.11) and mortality (OR 0.61, 95% CI
0.16–2.27; P = 0.46) between the two techniques. The LDP group
experienced fewer surgical site infections (OR 0.37, 95% CI 0.18–
0.75; P = 0.006), but other postoperative complications, such as
intra-abdominal abscesses (OR 0.78, 95% CI 0.25–2.45; P = 0.67),
intra-abdominal fluid collections (OR 1.47, 95% CI 0.67–3.22;
P = 0.34) and postoperative haemorrhage (OR 1.87, 95% CI
0.59–5.95; P = 0.29), were found to occur at similar frequencies
in both groups. In addition, rates of reoperation (OR 0.90, 95%
CI 0.43–1.84; P = 0.76) and readmission (OR 0.70, 95% CI 0.41–
1.21; P = 0.20) did not differ between the groups (Fig. 4).
Sensitivity and subgroup analysis
Sensitivity analyses were carried out by excluding each study from
the analysis of each outcome measure. These exclusions did not
alter the results obtained in cumulative analyses. In addition, sub-
group analyses were undertaken for all outcome measures by
including only high-quality studies. Analysis of the high-quality
studies showed time to first flatus to be significantly shorter
(WMD -1.80 days, 95% CI -2.14 to -1.47; P < 0.00001). However,
the analyses for other outcomes did not change in comparison
with previous analyses. These are summarized in Table 4.
Publication bias
A funnel plot based on the incidence of pancreatic fistula is shown
in Fig. 5. None of the studies lies outside the limits of the 95% CI
and hence there is no evidence of publication bias.
Discussion
Gagner and Pomp39 are considered to have pioneered the intro-
duction of laparoscopy in pancreatic surgery for chronic pancre-
atitis and published the first description of an LDP. Initially,
laparoscopy was mainly used for diagnostic purposes in pancrea-
tology. However, laparoscopic pancreatic resections are gaining in
popularity as a result of improvements in technology and increas-
ing laparoscopic surgical experience. Distal pancreatectomy,
which involves the resection of the pancreas to the left of the
superior mesenteric vessels, is regarded as the standard procedure
in chronic pancreatitis or benign and malignant tumours in the
body or tail of the pancreas.40 The increased use of LDP represents
a paradigm shift from the practice of ODP and the former is now
recognized as providing feasible, safe and effective treatment for
some conditions of the pancreas.3
The results of the present meta-analysis favour the laparoscopic
approach with regard to intraoperative blood loss and blood
transfusion rate. Interestingly, there was no difference in operating
time between the laparoscopic and open interventions, although
the pooled estimate tends to favour the ODP group. This may
reflect the fact that the current data were not stratified according
to surgical experience, although stage on the learning curve has
been shown to affect intraoperative blood loss, operation time
and other intraoperative parameters.4 Moreover, patient-specific
factors, such as localized fibrosis, inflammatory changes caused by
the tumour and tumour infiltration can also prolong the duration
of surgery.5
En bloc splenectomy is usually performed during conventional
ODP. Some studies have advocated splenic preservation when-
ever possible as it has been found to be associated with a reduced
incidence of perioperative infectious complications and severe
complications, and a shorter hospital stay.41–44 The present
results illustrate that LDP favours splenic preservation. These
findings are consistent with the higher rates of splenic preserva-
tion, of up to 85% in some series, reported after LDP,45 which
may be attributable to the improved vision afforded by the lap-
aroscopic approach, which, in turn, facilitates the more accurate
Study or Subgroup
Kim et al. 2008
(d)
DiNorcia et al. 2010
Casadei et al. 2010
Waters et al. 2010
Jayaraman et al. 2010
Abu et al. 2011
Butturini et al. 2012
Fox et al. 2012
Mehta et al. 2012
Limongelli et al. 2012
Total (95% CI)
Total events
Heterogeneity: Tau² = 0.35; Chi² = 19.86, d.f. = 9 (P = 0.02); I² = 55%
Test for overall effect: Z = 3.62 (P = 0.0003)
Events
38
11
4
5
14
14
19
15
21
5
146
Total
93
71
22
18
74
35
43
42
30
16
444
Events
2
26
4
3
33
3
8
17
9
3
108
Total
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dissection of the pancreas from the splenic vessels and the splenic
hilum.31,32
Margin-negative resection is the only way of curing pancreatic
cancer.46 The success of any oncological operation is determined
by the achievement of tumour-free margins and lymph node
yield. Some studies in the past have suggested that pancreatic
adenocarcinoma is a contraindication to laparoscopic resec-
tion47,48 because the role and oncologic safety of laparoscopic
resection in pancreatic cancer remain unknown. Recent studies49,50
have shown that the laparoscopic approach to malignant pancre-
atic tumours is feasible and results in similar rates of morbidity
and mortality as it does in benign tumours. Of the studies
included in the present analyses, only a few studies21,30 with small
sample sizes reported this outcome and thus the available data are
not sufficient to make a cumulative analysis. Furthermore, none of
the studies provide data on longterm oncologic follow-up and
therefore additional well-designed studies are needed to provide
convincing evidence.
Laparoscopic surgery has the advantage of requiring smaller
incisions and less bowel manipulation than does open surgery and
thereby reduces pain and analgesic requirements, and facilitates
the earlier recovery of bowel function and ambulation.5,6 The
results of this present meta-analysis were found to be consistent
with published data in terms of indicating a shorter time to oral
intake and shorter hospital stay in LDP patients than in ODP
patients. When only high-quality studies were included in the
analysis, time to first flatus was found to be greatly reduced in the
LDP group. Additionally, a low rate of conversion to open surgery
was observed, which highlights the feasibility of the laparoscopic
approach.
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Figure 3 Forest plots illustrating the results of a meta-analysis comparing postoperative recovery outcomes in laparoscopic and open distal
pancreatectomy. Pooled weighted mean differences (WMDs) with 95% confidence intervals (CIs) were calculated using the random-effects
model. (a) Time to first flatus. (b) Time to oral intake. (c) Length of hospital stay. SD, standard deviation
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Figure 4 Forest plots illustrating the results of a meta-analysis comparing postoperative complications in laparoscopic and open distal
pancreatectomy. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using the fixed-effects model. (a) Clinically
significant fistula. (b) Postoperative haemorrhage. (c) Intra-abdominal abscess. (d) Intra-abdominal fluid collections. (e) Surgical site infection.
(f) Mortality. (g) Reoperation. (h) Readmission
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The present analysis found that surgical site infections
occurred less frequently in the LDP group compared with the
ODP group. This may reflect the association between laparo-
scopic surgery and reduced surgical trauma, which results in a
less acute phase response compared with open surgery, and the
fact that local (peritoneal) immune function is affected by
carbon dioxide as a result of pneumoperitoneum.51 The present
analyses failed to demonstrate any differences between the LDP
and ODP groups with regard to postoperative mortality, haem-
orrhage, reoperation rate, readmission rate, intra-abdominal
fluid collections and intra-abdominal abscesses. It is of note that
the sample sizes for reporting these complications were small;
studies with larger sample sizes are needed to facilitate an accu-
rate summary. It was not possible to undertake cumulative
analyses to assess overall morbidity, as reported in many studies,
because the criteria used to define such complications varied
among the studies. Criteria for assessing morbidity included
the DeOliveira scoring system, the Martin scoring system, the
National Cancer Institute’s common toxicity criteria and the
Clavien classification system; it is inappropriate to pool results
obtained using such varied systems in order to make a cumula-
tive analysis.
Pancreatic fistula remains the most challenging complication in
pancreatic surgery as it can lead to intra-abdominal abscess,
delayed gastric emptying, haemorrhage, sepsis and electrolyte
imbalances.52 Reported rates of pancreatic fistula in distal pancre-
atectomy vary between 23% and 26%.53,54 In the present analysis,
the pooled results show no significant difference in the rate of
pancreatic fistula between the LDP (17%) and ODP (18%) groups
and no difference in the rate of clinically significant fistula. It is
important to note that although the majority of the reports
included in the present analysis used the ISGPF definition of
pancreatic fistula, variation exists in this regard and therefore, in
order to achieve homogeneity and increase the reliability of the
present results, only studies that used the ISGPF definition were
included in the analysis.
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This meta-analysis of non-randomized studies may have
several limitations, which must be taken into account when con-
sidering the results. Firstly, all of the studies included were non-
randomized in nature and therefore the results provide only a
possible estimate. This remains the biggest limitation of this study
and results in a weak level of evidence. However, the present study
made a strong attempt to select the best evidence available by
selecting high-quality studies and pooling their findings. This
does not resolve the problem, but it does improve the quality of
the synthesized data and adds reliability to the results. It also
highlights the need for better designed randomized studies that
are able to resolve all of the relevant questions. It is hoped that this
will also provide guidelines for the design of future trials on the
subject. Secondly, it is important to note that the results were not
stratified according to whether the underlying pathology was
benign or malignant in nature as the studies included patients
with different types of pancreatic disease. This may have an effect
on the outcome measures. Thirdly, significant heterogeneity was
seen among the included studies for some outcome measures.
This may well reflect differences in adjuvant treatment measures
and medical insurance systems. However, investigation of this
heterogeneity through meta-regression was not possible because
of the small number of studies and the unavailability of relevant
data. Additionally, it will be of crucial importance to ascertain the
financial implications of these procedures in order to make rec-
ommendations for their specific indications.
Conclusions
In conclusion, this is the most comprehensive review to date to
compare outcomes of LDP and ODP. The present results indicate
that LDP is a safe and feasible technique in comparison with ODP.
The current findings are reliable and the pooled estimates enable
the resolution of some of the discrepancies in data among indi-
vidual studies in the literature. However, these results need to be
validated in large, well-designed randomized controlled trials.
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